From: http://ping.fm/Dsf5D
Posted at 05:20 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 05:15 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 05:09 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 05:08 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 05:06 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 05:02 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 04:57 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 04:56 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 04:55 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 04:54 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 04:53 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 04:44 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 04:24 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Posted at 04:22 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
Avandia, the GlaxoSmithKline oral antidiabetic drug rosiglitazone maleate used to treat type II diabetes increases the risk of certain cardiovascular events according to recent studies. According to data reported to the FDA, adverse events of heart failure in patients using Avandia has been reported on since 2002 and now totals over 415 events. A New England Journal of Medicine study released in May 2007 showed a 43 percent increase in heart attacks in people using Avandia.
Posted at 04:21 PM in Business | Permalink | Comments (0)
Reblog
(0)
| |
